Urolog. pro Praxi, 2010; 11(2): 90-93

A satisified patient as an optimal goal of erectile dysfunction treatment

MUDr.Ondřej Trojan
Psychiatrická a sexuologická ambulance, Praha

The paper mentions the basics of erectile dysfunction treatment, summarizes the experience of the first decade of existence of PDE5

inhibitors as well as addresses the expectations of patients and their partners as a factor relevant to satisfaction. The model of optimal

combined approach is also outlined. The previously published facts are summarized and updated in order to provide a most accurate

outline for everyday diagnostic-therapeutic use.

Keywords: erectile dysfunction, PDE5 inhibitors, sildenafil, tadalafil, vardenafil satisfaction, erection, sexuality

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Trojan O. A satisified patient as an optimal goal of erectile dysfunction treatment. Urol. praxi. 2010;11(2):90-93.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Trojan O. Možnosti léčby erektilní dysfunkce: kde jsme a kam se ubíráme? Causa Subita 2003; 6(2): 77-80.
    2. Brock G. Issues in the Assessment and Treatment of Erectile Dysfunction: Individualizing and Optimizing Therapy for the, ,Silent Majority" CME/WEB.
    3. Kolektiv. Farmakoterapie erektilní dysfunkce - 1. část, Farmakoterapeutické informace; 2004; No. 3; 1-4.
    4. Mládek I. GLOSA: Neskutečné přednosti mužské impotence, Denik.cz, 31. 7. 2007.
    5. Žourková A. Měření poruch sexuálních funkcí při léčbě psychofarmaky. Psychiat. pro Praxi, 2002; 2: 50-53.
    6. Dean J, et al. J Sex Med 2006; 3: 650-661.
    7. Fisher W, et al. J Sex Med 2005; 2: 675-684.
    8. Montorsi F. Ústní sdělení - Symposium o léčbě ED, Kongres EAU, březen 2008.
    9. Donatucci CF, et al. Current Medical Research And Opinion 2008; 24(12): 3383-3392. Go to original source... Go to PubMed...
    10. Porst H, et al. Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5 mg and 10 mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. European Urology 2006; 50: 351-359. Go to original source... Go to PubMed...
    11. Porst H, et al. Long-Term Safety and Efficacy of Tadalafil 5 mg Dosed Once Daily in Men with Erectile Dysfunction. J Sex Med 2008; 5(9): 2160-2169. Go to original source... Go to PubMed...
    12. Rajfer J, et al. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US; International Journal of Impotence Research 2007; 19: 95-103. Go to original source... Go to PubMed...
    13. De Busc R, Drory R, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease: Recommendation of the Priceton Consensus panel. Am J Cardiol 2000; 86: 175-181. Go to original source... Go to PubMed...
    14. Kloner RA, et al. Am J Cardiol 2006; 97: 1778-1784.
    15. Albert Einstein College of Medicine (2006, Dec. 4). Gene Therapy For Erectile Dysfunction Shows Promise In Clinical Trial; Melman, A., Human Gene Therapy. December 2006 issue (Vol. 17, No. 12).
    16. Utiger RD. A pill for impotence. N Engl J Med. 1998; 338: 1458-1459. Go to original source... Go to PubMed...
    17. Leiblum SR. After Sildenafil: Bridging the Gap between Pharmacologic Treatment and Satisfying Sexual relationships, J Clin Psychiatry 2002; suppl 5: 17-22.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.